Synthesis and Biological Evaluation of Prodrugs Based on the Natural Antibiotic Duocarmycin for Use in ADEPT and PMT
2011 | journal article. A publication with affiliation to the University of Göttingen.
Jump to: Cite & Linked | Documents & Media | Details | Version history
Cite this publication
Synthesis and Biological Evaluation of Prodrugs Based on the Natural Antibiotic Duocarmycin for Use in ADEPT and PMT
Tietze, L. F.; Schmuck, K.; Schuster, H. J.; Mueller, M. & Schuberth, I. (2011)
Chemistry - A European Journal, 17(6) pp. 1922-1929. DOI: https://doi.org/10.1002/chem.201002798
Documents & Media
Details
- Authors
- Tietze, Lutz Friedjan; Schmuck, Kianga; Schuster, Heiko J.; Mueller, Michael; Schuberth, Ingrid
- Abstract
- Chemotherapy of malign tumors is usually associated with serious side effects as common anticancer drugs lack selectivity. An approach to deal with this problem is the antibody-directed enzyme prodrug therapy (ADEPT) and the prodrug monotherapy (PMT). Herein, the synthesis and biological evaluation of new glycosidic prodrugs suitable for both concepts are described. All prodrugs but one are stable in human serum and show QIC(50) values (IC(50) of prodrug/IC(50) of prodrug in the presence of the appropriate glycohydrolase) of up to 6500. This is the best value found so far for compounds interacting with DNA.
- Issue Date
- 2011
- Status
- published
- Publisher
- Wiley-blackwell
- Journal
- Chemistry - A European Journal
- ISSN
- 0947-6539
